Center for Molecular Medicine and Division of Vascular Surgery, Department of Molecular Medicine and Surgery, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.
Eur J Vasc Endovasc Surg. 2011 Dec;42(6):722-30. doi: 10.1016/j.ejvs.2011.05.023. Epub 2011 Jul 7.
Strokes, a major cause of disability, are often caused by embolism from unstable carotid plaques. The aim of this study was to validate a biobank of human carotid endarterectomies as a platform for further exploration of pathways for plaque instability. For this purpose, we investigated the relationship between clinical parameters of plaque instability and expression of genes previously shown to be associated with either plaque instability or healing processes in the vessel wall.
A database of clinical information and gene-expression microarray data from 106 carotid endarterectomies were used.
Expression of matrix metalloproteinase (MMP)-9 and MMP-7 was 100-fold higher in plaques than in normal artery. In general, genes associated with inflammation (such as RANKL and CD68) were overexpressed in symptomatic compared with asymptomatic plaques. Plaques obtained from patients undergoing surgery within 2 weeks after an embolic event showed up-regulation of genes involved in healing reactions in the vessel wall (including elastin and collagen). Statin treatment, as well as echodense lesions, were associated with a more stable phenotype.
Here, we demonstrate that gene-expression profiles reflect clinical parameters. Our results suggest that microarray technology and clinical variables can be used for the future identification of central molecular pathways in plaque instability.
中风是一种主要的致残原因,通常由不稳定的颈动脉斑块引起的栓塞所致。本研究旨在验证人类颈动脉内膜切除术的生物库,作为进一步探索斑块不稳定途径的平台。为此,我们研究了斑块不稳定的临床参数与先前显示与斑块不稳定或血管壁愈合过程相关的基因表达之间的关系。
使用了 106 例颈动脉内膜切除术的临床信息和基因表达微阵列数据数据库。
基质金属蛋白酶(MMP)-9 和 MMP-7 的表达在斑块中比在正常动脉中高 100 倍。一般来说,与无症状斑块相比,炎症相关基因(如 RANKL 和 CD68)在有症状的斑块中过度表达。在栓塞事件发生后 2 周内接受手术的患者中获得的斑块显示与血管壁愈合反应相关的基因上调(包括弹性蛋白和胶原蛋白)。他汀类药物治疗以及回声致密斑块与更稳定的表型相关。
在这里,我们证明了基因表达谱反映了临床参数。我们的结果表明,微阵列技术和临床变量可用于未来识别斑块不稳定的核心分子途径。